Congratulations to the six research groups chosen for the TANDEM 2023 collaborative funding program
This year, six research groups working in Lausanne, Geneva, Bern and Bellinzona were awarded a TANDEM grant.
Each team, consisting of a clinician and a basic research scientist, will address a question of direct clinical relevance from two angles: that of understanding the molecular mechanisms involved and that of directly improving cancer patient care.
